Results 261 to 270 of about 72,749 (293)
Some of the next articles are maybe not open access.
Catheterization and cardiovascular interventions, 2018
Studies comparing drug coated balloons (DCB) with new generation drug‐eluting stents (nDES) for the treatment of de novo coronary artery lesions are lacking.
D. Venetsanos +6 more
semanticscholar +1 more source
Studies comparing drug coated balloons (DCB) with new generation drug‐eluting stents (nDES) for the treatment of de novo coronary artery lesions are lacking.
D. Venetsanos +6 more
semanticscholar +1 more source
In-stent Restenosis of drug-eluting Stents
Future Cardiology, 2013Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic ...
Ron Waksman +2 more
openaire +2 more sources
Drug-Eluting Stents in the Elderly [PDF]
Current Treatment Options in Cardiovascular Medicine, 2010 The introduction of drug-eluting stents (DES) in 2003 has had a great impact on the management of coronary artery disease in the United States. The application of DES to older adults, the population with the highest prevalence of and worst prognosis for coronary artery disease, remains relatively more controversial.
Laura Mauri +2 more
openaire +2 more sources
WIREs Nanomedicine and Nanobiotechnology, 2009
AbstractThis paper reviews the development of coronary stents from a polymer scientist's view point, and presents the first results of an interdisciplinary team assembled for the development of new stent systems. Poly(styrene‐b‐isobutylene‐b‐styrene) block copolymer (SIBS), a nanostructured thermoplastic elastomer, is used in clinical practice as the ...
Chris Frethem +8 more
openaire +3 more sources
AbstractThis paper reviews the development of coronary stents from a polymer scientist's view point, and presents the first results of an interdisciplinary team assembled for the development of new stent systems. Poly(styrene‐b‐isobutylene‐b‐styrene) block copolymer (SIBS), a nanostructured thermoplastic elastomer, is used in clinical practice as the ...
Chris Frethem +8 more
openaire +3 more sources
Mathematical Medicine and Biology, 2010
In this study, we consider a family of mathematical models to describe the elution of drug from polymer-coated stents into the arterial wall. Our models include the polymer layer, the media, the adventitia, a possible topcoat polymer layer and atherosclerotic plaque.
McGinty, Sean +3 more
openaire +4 more sources
In this study, we consider a family of mathematical models to describe the elution of drug from polymer-coated stents into the arterial wall. Our models include the polymer layer, the media, the adventitia, a possible topcoat polymer layer and atherosclerotic plaque.
McGinty, Sean +3 more
openaire +4 more sources
2011
Coronary stents have revolutionized the management of patients with obstructive coronary artery disease. This chapter will review the problems associated with percutaneous coronary intervention when performed using balloon angioplasty and bare-metal stents, before discussing the first and second generation drug-eluting stents (DESs).
Scot Garg +2 more
openaire +4 more sources
Coronary stents have revolutionized the management of patients with obstructive coronary artery disease. This chapter will review the problems associated with percutaneous coronary intervention when performed using balloon angioplasty and bare-metal stents, before discussing the first and second generation drug-eluting stents (DESs).
Scot Garg +2 more
openaire +4 more sources
Comparison of drug eluting versus bare metal stents for pulmonary vein stenosis in childhood
Catheterization and cardiovascular interventions, 2019Comparison of outcomes using bare metal (BMS) and drug‐eluting (DES) stents in pulmonary vein stenosis (PVS).
Asra Khan, A. Qureshi, H. Justino
semanticscholar +1 more source
Polymers for Drug Eluting Stents
Current Pharmaceutical Design, 2010Currently approved drug eluting stents (DES) consist of a metallic scaffold and an elutable drug dispersed in a polymer matrix that conformally surrounds the struts. These primarily biostable polymers bind the drug to the stent and modulate the elution of the drug into the arterial tissue.
Ted Parker, Robert Falotico, Vipul Dave
openaire +3 more sources
Catheterization and cardiovascular interventions, 2016
Historically, percutaneous coronary intervention (PCI) of bifurcation lesions was associated with worse procedural and clinical outcomes when compared with PCI of non‐bifurcation lesions. Newer generation drug‐eluting stents (DES) might improve long‐term
M. Grundeken +22 more
semanticscholar +1 more source
Historically, percutaneous coronary intervention (PCI) of bifurcation lesions was associated with worse procedural and clinical outcomes when compared with PCI of non‐bifurcation lesions. Newer generation drug‐eluting stents (DES) might improve long‐term
M. Grundeken +22 more
semanticscholar +1 more source
Drug-eluting stents to prevent stent thrombosis and restenosis
Expert Review of Cardiovascular Therapy, 2016Although first-generation drug-eluting stents (DES) have significantly reduced the risk of in-stent restenosis, they have also increased the long-term risk of stent thrombosis. This safety concern directly triggered the development of new generation DES,
Eui Im, M. Hong
semanticscholar +1 more source